• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

TASAKI Yoshikazu  田崎 嘉一

ORCIDConnect your ORCID iD *help
… Alternative Names

田崎 嘉一  タサキ ヨシカズ

Less
Researcher Number 60374807
Other IDs
Affiliation (Current) 2025: 旭川医科大学, 大学病院, 教授
Affiliation (based on the past Project Information) *help 2025: 旭川医科大学, 大学病院, 教授
2022 – 2023: 旭川医科大学, 大学病院, 教授
2013 – 2021: 旭川医科大学, 医学部, 教授
2010 – 2012: 旭川医科大学, 医学部, 准教授
2005: Asahikawa Med.College, Department of Hospital Pharm.acy, 医学部, 助教授
Review Section/Research Field
Principal Investigator
Basic Section 47060:Clinical pharmacy-related / Medical pharmacy
Except Principal Investigator
Basic Section 47060:Clinical pharmacy-related / Basic Section 59010:Rehabilitation science-related / Medical pharmacy
Keywords
Principal Investigator
パーキンソン病進行抑制薬 / Akt / 細胞死抑制 / meloxicam / オキシカム系NSAIDs / meloxicam誘導体 / オキシカム系NSAIDs / 神経細胞死抑制 / パーキンソン病 / Akt … More / 新規抗パーキンソン病薬 / 新規治療薬候補 / meloxicam誘導体の開発 / ドラッグリポジショニング / POC試験 / 神経細胞死 / 新規パーキンソン病治療薬 / 進行抑制薬 / mTOR / TrkA / 神経細胞死抑制薬 / 細胞生存シグナル / ドラッグリプロファイリング / 新規進行抑制薬 / メロキシカム / オキシカム系非ステロイド性抗炎症薬 / パーキンソン病治療薬 / 新規治療薬 / PI3kinase/Akt経路 / 新規メカニズム / シグナル伝達 / NSAIDs / オキシカム系 / 臨床薬学 … More
Except Principal Investigator
抗菌薬 / 薬剤性腎障害 / ドラッグリポジショニング / ビッグデータ / 尿細管保護薬 / 介護システム / オンライン診療 / リハビリテーション / 転倒予防遠隔リハビリテーション / ICT / IoT / リアビリテーション / 遠隔医療 / basal ganglia / extrapyramidal system / Tandospirone / 5-HT1A receptor agonist / Parkinson disease / ラット / 5HT1A受容体作動薬 / マイクロダイアリシス / グルタミン醜 / 片側パーキンソン病モデル / 細胞死 / 保護効果 / SH-SY5Y細胞 / 5HT1A受容体作動 / 基底核 / 錐体外路 / タンドスピロン / 5HT1A受容体作動薬物 / パーキンソン病 Less
  • Research Projects

    (9 results)
  • Research Products

    (27 results)
  • Co-Researchers

    (14 People)
  •  新規パーキンソン病治療薬開発のための作用機序解明Principal Investigator

    • Principal Investigator
      田崎 嘉一
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Asahikawa Medical College
  •  ビッグデータの融合解析を基盤にした尿細管保護薬の開発

    • Principal Investigator
      中馬 真幸
    • Project Period (FY)
      2023 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Asahikawa Medical College
  •  Acquisition of candidate compounds as novel disease-modifying antiparkinsonian drugs for clinical trialPrincipal Investigator

    • Principal Investigator
      田崎 嘉一
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Asahikawa Medical College
  •  Development of novel neuroprotective oxicam derivatives for the treatment of Parkinson's diseasePrincipal Investigator

    • Principal Investigator
      Tasaki Yoshikazu
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Asahikawa Medical College
  •  Establishment of care system using telemedicine in medical depopulated areas

    • Principal Investigator
      吉田 晃敏
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 59010:Rehabilitation science-related
    • Research Institution
      Asahikawa Medical College
  •  Preclinical Proof-of-Concent research targeting development of novel neuroprotective drugs for Pankinson's disease.Principal Investigator

    • Principal Investigator
      Tasaki Yoshikazu
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Medical pharmacy
    • Research Institution
      Asahikawa Medical College
  •  Development of the antiparkinsonian drug with novel mechanism by drug-reprofiling.Principal Investigator

    • Principal Investigator
      TASAKI YOSHIKAZU
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Medical pharmacy
    • Research Institution
      Asahikawa Medical College
  •  Development of oxicam-bearing non-steroidal anti-inflammatory drugs with novel anti-parkinsonian mechanism.Principal Investigator

    • Principal Investigator
      TASAKI Yoshikazu
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Medical pharmacy
    • Research Institution
      Asahikawa Medical College
  •  5-HT1A agonists, ameliorate movement disorder via non-dopaminergic systems in Parkinson's patients.

    • Principal Investigator
      MATSUBARA Kazuo
    • Project Period (FY)
      2003 – 2005
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Medical pharmacy
    • Research Institution
      Asahikawa Medical College

All 2023 2019 2013 2012 2011 2010 2006

All Journal Article Presentation Patent

  • [Journal Article] The Effect of Concomitant Usage of Analgesics on Immune Checkpoint Inhibitor-related Interstitial Lung Disease2023

    • Author(s)
      Manabe T, Iwayama K, Chuma M, Tasaki Y, Matsumoto S.
    • Journal Title

      In Vivo

      Volume: 37 Issue: 3 Pages: 1260-1265

    • DOI

      10.21873/invivo.13203

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23K06208
  • [Journal Article] Concomitant Use of Multiple Nephrotoxins including Renal Hypoperfusion Medications Causes Vancomycin-Associated Nephrotoxicity: Combined Retrospective Analyses of Two Real-World Databases2023

    • Author(s)
      Bando T, Chuma M, Hamano H, Niimura T, Okada N, Kondo M, Izumi Y, Ishida S, Yoshioka T, Asada M, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Izawa-Ishizaka Y, Azuma M, Yanagawa H, Tasaki Y, Ishizawa K.
    • Journal Title

      Acta Medica Okayama

      Volume: 77 Issue: 6 Pages: 595-605

    • DOI

      10.18926/AMO/66151

    • URL

      https://ousar.lib.okayama-u.ac.jp/66151

    • Language
      English
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23K06208
  • [Journal Article] メロキシカムは,マウスパーキンソン病モデルにおいて,Aktシグナル維持により運動障害とドパミン神経変性を改善する2013

    • Author(s)
      田崎嘉一,山本譲,大村友博,坂口智己,木村周古,大滝康一,小野尚志,須野 学,浅利 優,大久保知子,野田敏宏,粟屋 敏雄,清水惠子,松原和夫.
    • Journal Title

      北海道医学雑誌

      Volume: 88(1) Pages: 45-45

    • NAID

      10031148191

    • Data Source
      KAKENHI-PROJECT-22590129
  • [Journal Article] Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.2012

    • Author(s)
      Tasaki Y, Yamamoto J, Omura T, Sakaguchi T, Kimura N, Ohtaki K, Ono T, Suno M, Asari M, Ohkubo T, Noda T, Awaya T, Shimizu K, Matsubara K.
    • Journal Title

      Neurosci Lett

      Volume: 521 Issue: 1 Pages: 15-19

    • DOI

      10.1016/j.neulet.2012.05.045

    • NAID

      120006522757

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22590129, KAKENHI-PROJECT-23590841, KAKENHI-PROJECT-23790722, KAKENHI-PROJECT-24590176
  • [Journal Article] Oxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated neuroprotection against 1-methyl-4- phenyl, pyridinium-induced cytotoxicity.2012

    • Author(s)
      Tasaki Y, Yamamoto J, Omura T, Noda T, Kamiyama N, Yoshida K, Satomi M, Sakaguchi T, Asari M, Ohkubo T, Shimizu K, Matsubara K.
    • Journal Title

      Eur J Pharmacol.

      Volume: 676 Issue: 1-3 Pages: 57-63

    • DOI

      10.1016/j.ejphar.2011.11.046

    • NAID

      120006522756

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22590129, KAKENHI-PROJECT-23590841, KAKENHI-PROJECT-23790722
  • [Journal Article] Oxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated neuroprotection against 1-methyl-4-phenyl-pyridinium-induced cytotoxicity2012

    • Author(s)
      Y.Tasaki, et al.
    • Journal Title

      European Journal of Pharmacology

      Volume: 676 Pages: 57-63

    • NAID

      120006522756

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Journal Article] Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y2010

    • Author(s)
      Tasaki Y, Omura T, Yamada T, Ohkubo T, Suno M, Iida S, Sakaguchi T, Asari M, Shimizu K, Matsubara K.
    • Journal Title

      cells.

      Volume: 1344 Pages: 25-33

    • DOI

      10.1016/j.brainres.2010.04.085

    • Data Source
      KAKENHI-PROJECT-22590129
  • [Journal Article] Meoxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxici ty via the phosphatidylinositol 3-kinase/Akt pathway in human dopamin ergic neuroblastoma SH-SY5Y cells2010

    • Author(s)
      Tasaki, et al.
    • Journal Title

      Brain Research

      Volume: 1344 Pages: 25-33

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Journal Article] Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.2006

    • Author(s)
      K.Matsubara, K Shimizu, M Suno, K.Ogawa, T.Awaya, T.Yamada, T.Noda, M.Satomi, K.Ohtaki, K.Chiba, Y.Tasaki, H.Shiono
    • Journal Title

      Brain Research (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-15590121
  • [Journal Article] Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions2006

    • Author(s)
      K.Matsubara, Y.Tasaki et al.
    • Journal Title

      Brain Research (in press)

    • Data Source
      KAKENHI-PROJECT-15590121
  • [Patent] PCT2019

    • Inventor(s)
      田崎嘉一、増野匡彦、大江知之、高橋恭子
    • Industrial Property Rights Holder
      田崎嘉一、増野匡彦、大江知之、高橋恭子
    • Industrial Property Rights Type
      特許
    • Filing Date
      2019
    • Overseas
    • Data Source
      KAKENHI-PROJECT-19K07186
  • [Patent] PCT2019

    • Inventor(s)
      田崎嘉一、増野匡彦、大江知之、高橋恭子
    • Industrial Property Rights Holder
      田崎嘉一、増野匡彦、大江知之、高橋恭子
    • Industrial Property Rights Type
      特許
    • Filing Date
      2019
    • Overseas
    • Data Source
      KAKENHI-PROJECT-19K07186
  • [Patent] 新規化合物を含むパーキンソン病治療薬2019

    • Inventor(s)
      田崎嘉一ほか
    • Industrial Property Rights Holder
      田崎嘉一ほか
    • Industrial Property Rights Type
      特許
    • Filing Date
      2019
    • Data Source
      KAKENHI-PROJECT-16K08389
  • [Presentation] Identification of prophylactic drug for vancomycin- associated nephrotoxicity using big data analysis2023

    • Author(s)
      Chuma M, Goda M, Zamami Y, Takechi K, Hamano H, Ishida S, Niimura T, Kondo M, Bando T, Izawa-Ishizawa Y, Tasaki Y, Ishizawa K
    • Organizer
      19th World Congress of Basic & Clinical Pharmacology (WCP2023)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-23K06208
  • [Presentation] ステロイドはバンコマイシン関連腎障害を予防する― ビッグデータ解析・基礎研究・臨床研究の統合による検討 ―2023

    • Author(s)
      中馬真幸, 合田光寛, 座間味義人, 濱野裕章, 武智研志, 石田俊介, 坂東貴司, 新村貴博, 近藤正輝, 石澤有紀, 田崎嘉一, 石澤啓介.
    • Organizer
      第44回日本臨床薬理学会学術総会/第97回日本薬理学会年会
    • Data Source
      KAKENHI-PROJECT-23K06208
  • [Presentation] Mammalian target of rapamycin (mTOR) mediates neuroprotection by oxicam nonsteroidal anti-inflammatory drugs against MPP+-induced SH-SY5Y cell death.2013

    • Author(s)
      Y. Tasaki, J. Yamamoto, T. Ohkubo, T. Noda, T. Omura, T. Ono, M. Suno, T. Sakaguchi, and K. Matsubara.
    • Organizer
      Sfn(Society for Neuroscience) 2013
    • Place of Presentation
      San diego(米国)
    • Data Source
      KAKENHI-PROJECT-25460204
  • [Presentation] Myeloid cell leukemia-1(Mcl-1) はSH-SY5Y細胞のMPP+誘発アポトーシスに対して保護作用を持つ2013

    • Author(s)
      田崎嘉一
    • Organizer
      日本薬学会第133回年会
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Presentation] Myeloid cell leukemia-1 (Mcl-1)はSH-SY5Y細胞のMPP+誘発アポトーシスに対して保護作用を持つ2013

    • Author(s)
      田崎嘉一
    • Organizer
      日本薬学会第133年会
    • Place of Presentation
      横浜
    • Year and Date
      2013-03-28
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Presentation] Oxicam non-steroidal anti-inflammatory drugs ameliorate motor dysfunction and dopaminergic degeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.2012

    • Author(s)
      Tasaki Y, Yamamoto J, Ohkubo T, Noda T, Omura T, Onoa T., Kimura N., Suno M., T. Sakaguchi, and Matsubara K
    • Organizer
      Neuroscience 2012
    • Place of Presentation
      シカゴ,米国
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Presentation] オキシカム系NSAIDsは、MPTP反復投与パーキンソン病モデルにおいて黒質線条体神経を保護し、行動異常を改善する2012

    • Author(s)
      田崎嘉一
    • Organizer
      日本薬学会第132年会
    • Place of Presentation
      札幌
    • Year and Date
      2012-03-30
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Presentation] オキシカム系NSAIDsは、MPTP反復投与パーキンソン病モデルにおいて黒質線条体神経を保護し、行動異常を改善する.2012

    • Author(s)
      田崎嘉一ら
    • Organizer
      日本薬学会第132年会
    • Place of Presentation
      札幌
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Presentation] Oxicam non-steroidal anti-inflammatory drugs ameliorate motor dysfunction and dopaminergic degeneration by maintaining Akt-signaling in a mouse Parkinson’s disease model.2012

    • Author(s)
      Tasaki Y
    • Organizer
      Society for Neuroscience 2012
    • Place of Presentation
      ニューオーリンズ
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Presentation] オキシカム系NSAIDsによる神経細胞死抑制作用はAkt/mTOR経路を介する2011

    • Author(s)
      田崎嘉一ら
    • Organizer
      日本薬学会第131年会
    • Place of Presentation
      静岡
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Presentation] Structural specificity of Akt-mediated neuroprotection by oxicam non-steroidal anti-inflammatory drugs against 1-methyl-4-phenyl pyridinium-induced cell death2011

    • Author(s)
      Y.Tasaki, et al., (田崎嘉一, ら)
    • Organizer
      XIX World Congress on Parkinson's Disease and Related Disorders
    • Place of Presentation
      Shanghai, China
    • Year and Date
      2011-12-14
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Presentation] オキシム系NSAIDsによる神経細胞死抑制作用は、Akt/MTOR経路を介する2011

    • Author(s)
      田崎, ら
    • Organizer
      第131回薬学会年会
    • Place of Presentation
      静岡(年会自体は中止、実績にはなるとのこと)
    • Year and Date
      2011-03-29
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Presentation] オキシカム系非ステロイド性抗炎症薬(NSAIDs)の新規抗パーキンソン病作用2011

    • Author(s)
      田崎嘉一
    • Organizer
      医療薬学フォーラム2011
    • Place of Presentation
      旭川(招待講演)
    • Year and Date
      2011-07-10
    • Data Source
      KAKENHI-PROJECT-22590129
  • [Presentation] Structural specificity of Akt-mediated neuroprotection by oxicam non- steroidal anti-inflammatory drugs against 1-methyl-4-phenyl pyridinium- induced cell death2011

    • Author(s)
      Tasaki Y, Yamamoto J, Omura T, Noda T, Kamiyama N, Yoshida K, Satomi M, Sakaguchi T, Asari T, Ohkubo T, Shimizu K and Matsubara K
    • Organizer
      PDRD
    • Place of Presentation
      上海,中国
    • Data Source
      KAKENHI-PROJECT-22590129
  • 1.  MATSUBARA Kazuo (20127533)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 8 results
  • 2.  Kamiyama Naoya (20431398)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 3.  FUKUDO Masahide (60437233)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  SHIMIZU Keiko (90312462)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  吉田 晃敏 (70125417)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  服部 ユカリ (00272899)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  大田 哲生 (20233132)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 8.  竹川 政範 (50216876)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  盛一 健太郎 (70455715)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 10.  藤谷 幹浩 (80322915)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 11.  山根 由起子 (80745282)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 12.  中馬 真幸 (20819289)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 13.  眞鍋 貴行 (60460698)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 14.  清水 惠子
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi